Kimer Med chief executive, Rick Kiessig is working in Nelson developing a broad-spectrum antiviral drug to help fight pandemics. A Nelson start-up hopes a new laboratory will speed up its work developing a broad-spectrum antiviral drug to help fight pandemics and diseases like dengue fever and HIV. Biotech company Kimer Med moved into its new lab in the Cawthron Institute’s Stoke premises in November, and is now recruiting extra staff to help develop the drug. The drug could help in the fight against future strains of Covid-19, or other viruses that may emerge. “We are excited to be able to assist Kimer Med make further scientific advances in this area.”

Source: Stuff November 27, 2022 23:37 UTC